Anti-fibrotic treatments for chronic liver diseases: the present and the future

scientific article published on 03 December 2020

Anti-fibrotic treatments for chronic liver diseases: the present and the future is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.3350/CMH.2020.0187
P932PMC publication ID8273638
P698PubMed publication ID33317250

P2093author name stringMasaru Enomoto
Norifumi Kawada
Hideki Fujii
Tsutomu Matsubara
Misako Sato-Matsubara
Naoshi Odagiri
P2860cites workNF-kappaB is a critical regulator of the survival of rodent and human hepatic myofibroblasts.Q54546261
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P921main subjectchronic liver diseaseQ5113984
P577publication date2020-12-03
P1433published inClinical and molecular hepatologyQ26853927
P1476titleAnti-fibrotic treatments for chronic liver diseases: the present and the future

Search more.